Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Conference
The Program Freedom Experience
Thank You for Attending the Program Freedom Experience. On January 17, 2018, Mitchell hosted the one-of-a-kind Program Freedom Experience
Workers' Comp
News Release
Business Insurance: Genex acquires pain intervention program provider
Disability management services company Genex Services L.L.C.
Workers' Comp
News Release
Genex Services Acquires PRIUM from Ameritox Expands Pain Management Services
Deal Boosts Industry-Leading Chronic Pain Intervention and UR Services Offerings WAYNE, PA A
Mitchell
Article
The Compliance Corner: New Physical Therapy Evaluation Codes for 2017: Moving Toward Value Based Payment
The American Medical Association (AMA) shook up the Property and Casualty industry by bringing a big change to the 2017 Current Procedural Terminol
Workers' Comp
Article
Technology Integrations Are Transforming How Pharmacy Benefits Managers Monitor Drug Therapies
Technology continues to transform the way we live and work, and the insurance industry is no exception.
Mitchell
Article
Winners to be announced at the P&C Conference in October
We are excited to announce the winners of our first annual Mitchell mPower Awards at our P&C conference, October 18, 2017.